Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression

Anuradha Tarafdar, Lisa E. M. Hopcroft, Paolo Gallipoli, Francesca Pellicano, Jennifer Cassels, Alan Hair, Koorosh Korfi, Heather G. Jørgensen, David Vetrie, Tessa L. Holyoake, Alison M. Michie

Blood (2017) 129 (2): 199–208.

https://doi.org/10.1182/blood-2016-09-742049

Published: 2017

Includes: Supplemental data

Journal Articles

Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1

Jiun-Han Lin, Ju-Yin Lin, Ya-Ching Chou, Mei-Ru Chen, Te-Huei Yeh, Chung-Wu Lin, Sue-Jane Lin, Ching-Hwa Tsai

Blood (2015) 125 (14): 2228–2238.

https://doi.org/10.1182/blood-2014-08-594689

Published: 2015

Includes: Supplemental data

Journal Articles

Genetic Alterations of the MHC Class II Transactivator CIITA Are Frequent in Primary Mediastinal Large B-Cell Lymphoma and Associated with Diminished MHC Class II Expression

Anja Mottok, MD, Bruce W. Woolcock, MSc, Fong Chun Chan, MSc, Adele Telenius, MSc, Elizabeth A. Chavez, Cg R.T, Merrill Boyle, B.Sc., Susana Ben-Neriah, MSc, Lisa M. Rimsza, MD, Reiner Siebert, MD, Randy D. Gascoyne, MD, Christian Steidl, MD

Blood (2014) 124 (21): 3040.

https://doi.org/10.1182/blood.V124.21.3040.3040

Published: 2014

Journal Articles

Molecular and Functional Characterization Of The Novel Protein-Coding Gene Tihl (Translocated in Hodgkin’s Lymphoma) in Hematopoiesis

Ujunwa Cynthia Okoye-Okafor, M.Sc., Laura Barreyro, M.Sc., Heng Rui Wang, M.Sc., Boris Bartholdy, Ph.D., Britta Will, PhD, Tihomira I Todorova, B.A., Swathi-Rao Narayanagari, M.Sc., Mario Pujato, M.Sc., Masahiro Kawahara, MD, PhD, Bruce W. Woolcock, MSc, Randy D. Gascoyne, MD, Christian Steidl, MD, Ulrich Steidl, MD PhD

Blood (2013) 122 (21): 3680.

https://doi.org/10.1182/blood.V122.21.3680.3680

Published: 2013

Journal Articles

Specific PML Isoforms and SATB1 Affect HLA Expression In Classical Hodgkin Lymphoma

Yuxuan Liu, Anke Van Den Berg, PhD, Bea Rutgers, Rianne Veenstra, Debora de Jong, Gertrud Kortman, Gustaaf van Imhoff, Lydia Visser, Arjan Diepstra, MD PhD

Blood (2013) 122 (21): 4234.

https://doi.org/10.1182/blood.V122.21.4234.4234

Published: 2013

Journal Articles

Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting T reg

Blood (2013) 122 (13): 2185–2194.

https://doi.org/10.1182/blood-2012-09-456988

Published: 2013

Includes: Supplemental data

Journal Articles

Identification of a Novel Protein-Coding Gene ( TIHL) and Its Functional Relevance in Myeloid Cells.

Ujunwa Cynthia Okoye-Okafor, M.Sc., Boris Bartholdy, Ph.D., Bruce Woolcock, M.Sc., Masahiro Kawahara, MD, PhD, Tihomira I Todorova, B.A., Randy D. Gascoyne, MD, Christian Steidl, MD, Ulrich Steidl, MD, PhD

Blood (2012) 120 (21): 2333.

https://doi.org/10.1182/blood.V120.21.2333.2333

Published: 2012

Journal Articles

Mutations of STAT6 DNA Binding Domain Are Characteristic of PMBL and Belong to the Genetic Signature of This Entity.

Marlene Ochmann, Francois Lemonnier, Diane Damotte, MD, Richard Delarue, MD, Susana Ben-Neriah, Noel Milpied, MD, Thierry Lamy, MD, PhD, Herve Tilly, MD, Randy D. Gascoyne, MD, Christian Steidl, MD, Philippe Gaulard, MD, Karen Leroy, MD

Blood (2012) 120 (21): 2645.

https://doi.org/10.1182/blood.V120.21.2645.2645

Published: 2012

Journal Articles

Loss of CIITA and MHC Class II Expression in Diffuse Large B-Cell Lymphoma Is Not Explained by Methylation of CIITA Promoters III and IV.

Sarah T Wilkinson, PhD, Diane R Fernandez, MD, Shawn P Murphy, PhD, Wing C. Chan, MD, Randy D. Gascoyne, MD, Elias Campo, MD, Elaine S. Jaffe, MD, Louis M. Staudt, MD, PhD, Jan Delabie, MD, PhD, Andreas Rosenwald, MD, Lisa M Rimsza, MD

Blood (2008) 112 (11): 1786.

https://doi.org/10.1182/blood.V112.11.1786.1786

Published: 2008

Journal Articles

E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII)

Nienke van der Stoep, Edwin Quinten, Marisa Marcondes Rezende, Peter J. van den Elsen

Blood (2004) 104 (9): 2849–2857.

https://doi.org/10.1182/blood-2004-03-0790

Published: 2004

NARROW

CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression

Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1

Genetic Alterations of the MHC Class II Transactivator CIITA Are Frequent in Primary Mediastinal Large B-Cell Lymphoma and Associated with Diminished MHC Class II Expression

Molecular and Functional Characterization Of The Novel Protein-Coding Gene Tihl (Translocated in Hodgkin’s Lymphoma) in Hematopoiesis

Specific PML Isoforms and SATB1 Affect HLA Expression In Classical Hodgkin Lymphoma

Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting T reg

Identification of a Novel Protein-Coding Gene ( TIHL) and Its Functional Relevance in Myeloid Cells.

Mutations of STAT6 DNA Binding Domain Are Characteristic of PMBL and Belong to the Genetic Signature of This Entity.

Loss of CIITA and MHC Class II Expression in Diffuse Large B-Cell Lymphoma Is Not Explained by Methylation of CIITA Promoters III and IV.

E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only